Skip to main content
Sisram Medical Ltd logo

Sisram Medical Ltd — Investor Relations & Filings

Ticker · 1696 ISIN · IL0011418113 HKEX Manufacturing
Open in API
Filings indexed 1,569 across all filing types
Latest filing 2022-11-29 Interim / Quarterly Rep…
Country HK Hong Kong
Listing HKEX 1696

About Sisram Medical Ltd

http://www.sisram-medical.com

Sisram Medical Ltd. is a global consumer wellness group specializing in medical aesthetics and minimally invasive solutions. Leveraging over two decades of expertise, the company is a leader in Energy-Based Devices (EBD), harnessing natural energy sources for both aesthetic and medical clinical indications. Sisram operates through a synergistic ecosystem of brands, providing medical-grade quality solutions to professional customers and consumers worldwide. Key segments include Alma, a provider of energy-based solutions for surgical and medical aesthetics markets; LMNT, a personal care brand for home use; Copulla, which offers end-to-end digital dentistry services; and a dedicated injectables portfolio. The company's extensive product range covers treatments such as hair removal, skin rejuvenation, body contouring, and dermal fillers.

Recent filings

Filing Released Lang Actions
ANNOUNCEMENT OF UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2022
Interim / Quarterly Report Classification · 100% confidence The document is titled 'ANNOUNCEMENT OF UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2022' and contains detailed financial statements including profit or loss, comprehensive income, financial position, segment information, and notes. It explicitly states it is an unaudited condensed consolidated interim financial statement prepared under IFRS and IAS 34 'Interim Financial Reporting'. The document length is about 15,000 characters, indicating it is a full report rather than a brief announcement. The content includes actual financial data and analysis for a six-month period, consistent with an Interim / Quarterly Report. Therefore, the document is best classified as an Interim / Quarterly Report (IR). H1 2023
2022-11-29 English
PROFIT WARNING
Earnings Release Classification · 95% confidence The document is a profit warning announcement by Reliance Global Holdings Limited. It references a preliminary review of unaudited management accounts for the six months ended 30 September 2022 (HY2022) and indicates an expected decrease in profit. The announcement states that the interim results will be published later, and this document serves as an early alert to shareholders and investors. The document length is short (2995 characters) and does not contain actual financial statements or detailed financial analysis, only a summary of expected performance. It is not the interim report itself but a notification about expected results. Therefore, it fits the category of an Earnings Release (ER), which is the initial announcement of quarterly or periodical financial results with key highlights only. H1 2023
2022-11-21 English
NOTIFICATION OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is a short announcement from Reliance Global Holdings Limited notifying the market and shareholders about an upcoming board meeting scheduled for 29 November 2022. The purpose of the meeting includes approving the interim results for the six months ended 30 September 2022. The document does not contain any financial data or detailed report content itself; it merely informs about the meeting date and agenda. The length is only 1375 characters, which is quite short and fits the pattern of an announcement rather than a full interim report. According to the rules, such a notification about a board meeting to approve interim results is best classified as a Regulatory Filing (RNS), since it is a general regulatory announcement and does not contain the actual interim report or financial statements.
2022-11-17 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 31 October 2022. It details movements in authorized/registered share capital, issued shares, and confirms no changes in share options, warrants, convertibles, or other agreements. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting monthly share capital and share issuance movements. It is not a financial report, earnings release, or management discussion, nor is it an announcement of voting results or a proxy statement. It is a regulatory filing reporting share capital and share issuance movements as required by exchange rules. The document length is 4438 characters, which is relatively short but contains substantive data on share capital movements, not just an announcement of a report. Therefore, the best fitting category is Regulatory Filings (RNS), as it is a compliance document reporting share capital movements under exchange rules but does not fit other more specific categories like Share Issue/Capital Change (SHA) which typically involves announcements of new share issues or capital changes rather than monthly returns. The document is a routine regulatory filing reporting share capital movements to the exchange.
2022-11-02 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2022
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return regarding movements in securities, specifically focusing on authorized and issued share capital, share options, convertibles, and confirmations related to securities issued by Reliance Global Holdings Limited. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with the Exchange Listing Rules. The content is regulatory in nature, providing updates on share capital and securities movements rather than financial performance or management commentary. It does not contain financial statements or earnings data, nor is it a report or presentation. The document is a regulatory filing reporting share capital movements and confirmations, fitting best under the category of Regulatory Filings (RNS).
2022-11-01 English
UPDATE ON THE DISCLOSEABLE AND CONNECTED TRANSACTIONS AND CONTINUING CONNECTED TRANSACTIONS RELATING TO THE SUBLICENSE AGREEMENT
Capital/Financing Update Classification · 95% confidence The document is an announcement from Sisram Medical Ltd regarding an update on discloseable and connected transactions related to an amended sublicense agreement. It details the background, terms, consideration, effective date, and implications under listing rules. The content focuses on contractual and transaction updates rather than financial results, management changes, or regulatory certifications. It is not a full financial report, earnings release, or management discussion. The document is lengthy (15,000 characters) and provides substantive details about a capital transaction involving licensing and payments, which aligns with capital/financing updates. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2022-10-26 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.